Complete financial analysis of Nanalysis Scientific Corp. (NSCIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nanalysis Scientific Corp., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Univanich Palm Oil Public Company Limited (UVPOF) Income Statement Analysis – Financial Results
- The New Ireland Fund, Inc. (IRL) Income Statement Analysis – Financial Results
- Sierra Oncology, Inc. (SRRA) Income Statement Analysis – Financial Results
- Shaanxi Zhongtian Rocket Technology Co., Ltd (003009.SZ) Income Statement Analysis – Financial Results
- Instal Kraków S.A. (INK.WA) Income Statement Analysis – Financial Results
Nanalysis Scientific Corp. (NSCIF)
About Nanalysis Scientific Corp.
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It operates through three segments: Nanalysis, RS2D, and Corporate. The company also offers software module packages; manufactures and sells cutting-edge electronics components for precision analytical instruments; and provides monitoring and supporting services for its NMR technologies. It sells its products directly, as well as through a network of distributors worldwide. The company is headquartered in Calgary, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.47M | 24.82M | 16.04M | 7.87M | 8.36M | 8.38M | 7.67M | 5.25M |
| Cost of Revenue | 24.50M | 13.68M | 5.80M | 2.71M | 2.30M | 2.98M | 2.77M | 2.15M |
| Gross Profit | 3.97M | 11.14M | 10.24M | 5.17M | 6.06M | 5.40M | 4.89M | 3.10M |
| Gross Profit Ratio | 13.95% | 44.88% | 63.83% | 65.62% | 72.45% | 64.41% | 63.83% | 59.12% |
| Research & Development | 679.00K | 1.47M | 643.00K | 476.00K | 270.00K | 166.00K | 0.00 | 0.00 |
| General & Administrative | 11.04M | 12.67M | 6.14M | 3.51M | 2.77M | 2.26M | 1.32M | 1.33M |
| Selling & Marketing | 1.35M | 2.36M | 2.14M | 3.24M | 2.45M | 2.52M | 1.96M | 1.57M |
| SG&A | 12.39M | 15.02M | 8.28M | 6.75M | 5.22M | 4.77M | 173.33K | 25.25K |
| Other Expenses | -9.10M | 4.56M | 2.51M | 1.68M | 775.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.97M | 21.05M | 11.43M | 8.91M | 5.99M | 5.11M | 173.33K | 25.25K |
| Cost & Expenses | 40.09M | 34.73M | 17.23M | 11.62M | 8.30M | 8.09M | 173.33K | 25.25K |
| Interest Income | 0.00 | 76.00K | 2.00K | 328.00K | 59.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 902.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.67M | 4.65M | 2.58M | 1.75M | 845.00K | 372.00K | 164.71K | 110.96K |
| EBITDA | -8.85M | -5.26M | 1.38M | -1.86M | 484.00K | 485.00K | 1.78M | 324.43K |
| EBITDA Ratio | -31.08% | -19.53% | 12.21% | -17.89% | 29.11% | 8.29% | -2.26% | -0.48% |
| Operating Income | -11.62M | -9.50M | -608.00K | -3.18M | 1.59M | 323.00K | -173.33K | -25.25K |
| Operating Income Ratio | -40.82% | -38.26% | -3.79% | -40.37% | 19.01% | 3.85% | -2.26% | -0.48% |
| Total Other Income/Expenses | -5.17M | -2.54M | -1.43M | -985.00K | -1.96M | -152.00K | -167.47K | -77.09K |
| Income Before Tax | -16.80M | -10.40M | -1.77M | -3.98M | -1.40M | 136.00K | -172.11K | -25.28K |
| Income Before Tax Ratio | -59.00% | -41.90% | -11.05% | -50.48% | -16.73% | 1.62% | -2.24% | -0.48% |
| Income Tax Expense | -11.00K | -484.00K | 581.00K | -297.00K | 261.00K | 62.00K | 210.00K | 143.00K |
| Net Income | -16.78M | -9.92M | -2.35M | -3.68M | -1.66M | 74.00K | -172.11K | -25.28K |
| Net Income Ratio | -58.96% | -39.95% | -14.67% | -46.71% | -19.85% | 0.88% | -2.24% | -0.48% |
| EPS | -0.17 | -0.11 | -0.03 | -0.06 | -0.03 | 0.00 | -0.17 | -0.03 |
| EPS Diluted | -0.17 | -0.11 | -0.03 | -0.06 | -0.03 | 0.00 | -0.17 | -0.03 |
| Weighted Avg Shares Out | 99.18M | 92.48M | 70.40M | 65.32M | 55.63M | 60.92M | 1.03M | 1.00M |
| Weighted Avg Shares Out (Dil) | 99.18M | 92.48M | 70.40M | 65.32M | 55.63M | 60.92M | 1.03M | 1.00M |
Nanalysis Announces First Quarter 2024 Results
Company Achieves Record Revenue Quarter CALGARY, AB , May 29, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces first quarter results...
Nanalysis Announces First Quarter 2024 Conference Call
Hosting Call at 5:00 pm ET on Wednesday, May 29th European Q&A Session on Thursday May 30th at 8:30am ET CALGARY, AB , May 21, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in...
Nanalysis Scientific Corp. (NSCIF) Q4 2023 Earnings Call Transcript
Nanalysis Scientific Corp. (OTCQX:NSCIF) Q4 2023 Earnings Conference Call April 29, 2024 5:00 PM ET Company Participants Matthew Selinger - Investor Relations Sean Krakiwsky - Founder and CEO Randall McRae - Chief Financial Officer Conference Call Participants Stefan Quenneville -...
Nanalysis Announces Fourth Quarter and Full Year 2023 Results
CALGARY, AB , April 29, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces fourth quarter and full year results for...
/C O R R E C T I O N -- Nanalysis Scientific Corp./
In the news release, Nanalysis Announces Full Year 2023 Conference Call, issued 11-Apr-2024 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the Hosting Call and European Q&A Session date mentioned should read "Monday, April 29th...
Nanalysis Announces Full Year 2023 Conference Call
Hosting Call at 5:00 pm ET on Thursday, April 25th European Q&A Session on Friday April 26 th at 8:30am ET CALGARY, AB , April 11, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a...
Nanalysis Scientific Corp. Announces Director Resignation
CALGARY, AB , April 10, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024, and the Board...
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
CALGARY, AB , April 4, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that its subsidiary...
Nanalysis Announces Upcoming Webinar and Conference Participation
CALGARY, AB , Feb. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and...
Nanalysis Achieves Record Revenue in Q4
CALGARY, AB , Feb. 6, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate...
Source: https://incomestatements.info
Category: Stock Reports